LOCALLY ADVANCED UNRESECTABLE ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Clinical trials for LOCALLY ADVANCED UNRESECTABLE ESOPHAGEAL SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED UNRESECTABLE ESOPHAGEAL SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED UNRESECTABLE ESOPHAGEAL SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can extra nutrition boost cancer treatment success?
Disease control Recruiting nowThis study looks at whether intensive nutritional support can help patients with advanced esophageal cancer who are receiving chemotherapy and immunotherapy before surgery. About 118 participants will be randomly assigned to either standard care or extra oral nutrition supplement…
Matched conditions: LOCALLY ADVANCED UNRESECTABLE ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Sichuan University • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New combo therapy aims to tame tough esophageal cancer
Disease control Recruiting nowThis study tests whether adding the immunotherapy drug camrelizumab to a short course of chemotherapy and radiation can better control advanced esophageal cancer that cannot be removed by surgery. About 98 participants will receive one of two treatment schedules. The goal is to s…
Matched conditions: LOCALLY ADVANCED UNRESECTABLE ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Ning Jiang, M.D./Ph.D. • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New pill combo offers hope for Hard-to-Treat esophageal cancer
Disease control Recruiting nowThis study is testing whether a chemotherapy pill (oral paclitaxel) combined with radiation can safely treat advanced esophageal cancer that cannot be removed by surgery. It is for people aged 70 or older, or those who cannot tolerate standard IV chemo. The goal is to control the…
Matched conditions: LOCALLY ADVANCED UNRESECTABLE ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Jiangsu Cancer Institute & Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC